Cardiovascular Disease to Affect 60% of U.S. Adults by 2050
A new report from the American Heart Association estimated that heart diseases could affect at least 60% of U.S. adults by 2050.... Read more.
NATO Developing ‘Land Corridors’ to Place U.S. Troops on Front Line of Ukraine
NATO is developing "land corridors" to place U.S. troops on the front line in Ukraine, according to a report from The Telegraph.... Read more.
U.S. Funding of Moderna Bird Flu Vaccine Expected Prior to Election
Some believe federal funding for a late-stage trial for Moderna's mRNA bird flu vaccine could occur as early as next month.... Read more.
U.N. Watch Accuses Special Rapporteur Albanese of Taking Payments from Activist Groups
Watchdog organization U.N. Watch accused Francesca Albanese, the Human Rights Council's special rapporteur, of taking payments from activist groups.... Read more.
NIH Scientists Received Millions of Dollars in Royalties from Big Pharma
A report from investigative group Open the Books found that scientists with the National Institutes of Health (NIH) were paid around $710 million from big pharma... Read more.
Harvard Removes DEI Requirement for Prospective Faculty
Harvard University's Faculty of Arts and Sciences has removed its diversity, equity, and inclusion (DEI) requirement for prospective faculty members.... Read more.
Fauci Says Unvaccinated are Responsible for 200,000 Deaths
During his June 3 appearance before Congress, former National Institute of Allergy and Infectious Diseases (NIAID) director Dr. Anthony Fauci claimed that those... Read more.
Columbia University Anti-Israel Encampment Returns During Class Reunions
Columbia University's anti-Israel protesters returned to the school to set up another encampment during class reunions.... Read more.
Scholastic Tells Teachers They ‘Absolutely Know Queer Children’
Scholastic recently released its 2024 "Read with Pride" campaign, telling educators they "absolutely know queer children."... Read more.
FDA Approves Moderna’s Development of mRNA RSV Vaccine
Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial... Read more.
